#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13250	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2567	637.2	0	.	n	.	0	A69G	SNP	69	69	A	519	519	G	845	G	845	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13250	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2567	637.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1900	1900	T	914	T,G,C	908,5,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13250	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2567	637.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1634	1634	C	872	C,T	871,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22210	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4052	682.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1986	1986	A	876	A	876	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22210	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4052	682.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2620	2620	C	786	C,T,A	784,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22210	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4052	682.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2694	2694	A	679	A	679	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22210	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4052	682.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3246	3246	C	809	C,A,T	805,3,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	2038	folP	852	852	99.88	folP.l6.c4.ctg.1	2041	124.5	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1077	1079	AAA	228;225;224	A,C;A,C;A,T	227,1;224,1;223,1	.	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	2038	folP	852	852	99.88	folP.l6.c4.ctg.1	2041	124.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1308	1310	AGC	198;199;200	A;G;C	198;199;200	folP.WHO_M_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4798	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3805	157.2	1	SNP	p	S91F	0	.	.	271	273	TCC	805	807	TCC	190;193;193	T;C,T;C	190;192,1;193	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4798	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3805	157.2	1	SNP	p	D95G	0	.	.	283	285	GAC	817	819	GAC	191;192;191	G,A;A,C;C	190,1;191,1;191	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4798	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3805	157.2	1	SNP	p	D95N	0	.	.	283	285	GAC	817	819	GAC	191;192;191	G,A;A,C;C	190,1;191,1;191	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1830	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1752	129.9	1	SNP	p	G45D	0	.	.	133	135	GGC	718	720	GGC	204;207;206	G;G;C	203;206;205	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	964	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1461	82.2	0	.	n	.	0	A197.	DEL	197	197	A	823	823	A	199	A	198	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4474	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3444	162.0	0	.	p	.	0	V716I	NONSYN	2146	2148	GTT	2710	2712	ATT	181;180;178	A,T;T;T	180,1;180;178	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4474	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3444	162.0	1	SNP	p	D86N	0	.	.	256	258	GAC	820	822	GAC	168;169;171	G;A;C	168;169;171	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4474	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3444	162.0	1	SNP	p	S87I	0	.	.	259	261	AGT	823	825	AGT	173;171;170	A;G,A;T,G	173;170,1;169,1	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4474	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3444	162.0	1	SNP	p	S87W	0	.	.	259	261	AGT	823	825	AGT	173;171;170	A;G,A;T,G	173;170,1;169,1	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4474	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3444	162.0	1	SNP	p	S87R	0	.	.	259	261	AGT	823	825	AGT	173;171;170	A;G,A;T,G	173;170,1;169,1	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4474	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3444	162.0	1	SNP	p	S88P	0	.	.	262	264	TCC	826	828	TCC	173;177;177	T,G;C;C	172,1;177;177	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3826	parE	1986	1986	100.0	parE.l15.c17.ctg.1	3266	145.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1927	1929	GGC	216;211;210	G;G;C	216;211;210	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3556	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	150.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1508	1510	GCA	227;229;229	G,A,T;C,T;A,C	224,1,2;228,1;228,1	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3556	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	150.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1511	1513	ATC	228;228;228	A;T;C	228;228;228	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3556	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	150.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1523	1525	GTG	235;234;234	G;T;G	235;234;234	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3556	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	150.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1523	1525	GTG	235;234;234	G;T;G	235;234;234	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3556	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	150.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2027	2029	ACC	215;214;213	A,C;C;C	214,1;214;213	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3556	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	150.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2081	2083	GCG	202;202;201	G;C;G,T	202;202;200,1	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3556	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	150.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2081	2083	GCG	202;202;201	G;C;G,T	202;202;200,1	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3556	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	150.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2204	2206	GGC	192;192;192	G,T;G;C	191,1;192;192	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3556	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	150.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2213	2215	GGC	197;198;197	G;G,T;C	197;197,1;197	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3556	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	150.3	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2231	2233	CTG	197;197;194	C,T;T,G;G	196,1;195,2;194	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5148	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3641	176.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1904	1906	CCG	209;207;210	C;C,T;G	209;206,1;210	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2204	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2340	117.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	803	803	C	164	C	164	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	276	porB1a	984	100	94.0	porB1a.l15.c4.ctg.1	182	52.9	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	62;59;57	A;C;G	62;59;57	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	276	porB1a	984	100	94.0	porB1a.l15.c4.ctg.1	182	52.9	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	21;16;15	C;A;A	21;16;15	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	276	porB1a	984	156	92.95	porB1a.l15.c4.ctg.5	156	40.1	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	20;22;23	T;T;A	20;22;23	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	276	porB1a	984	156	92.95	porB1a.l15.c4.ctg.5	156	40.1	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	50;50;50	C;A;T	50;50;50	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	276	porB1a	984	156	92.95	porB1a.l15.c4.ctg.5	156	40.1	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	50;50;50	A;G;T	50;50;50	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	276	porB1a	984	156	92.95	porB1a.l15.c4.ctg.5	156	40.1	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	50;50;50	T;A;C	50;50;50	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2676	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1858	178.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	549	551	GAA	252;251;249	G,T;A;A	251,1;251;249	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2676	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1858	178.3	0	.	p	.	0	T106I	NONSYN	316	318	ACC	753	755	ATC	219;220;219	A;T;C	219;220;219	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2676	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1858	178.3	0	.	p	.	0	N134D	NONSYN	400	402	AAT	837	839	GAT	206;207;209	G,T;A;T	205,1;207;209	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2676	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1858	178.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	960	962	TCA	245;244;247	T,G;C,A;A	244,1;243,1;247	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2676	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1858	178.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1089	1091	GTC	200;203;208	G,A;T,C;C,G	199,1;201,2;207,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2676	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1858	178.3	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1419	1421	GCA	209;212;213	G,C;C,A;A,C	208,1;211,1;211,2	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2676	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1858	178.3	1	SNP	p	G120K	1	.	.	358	360	AAG	795	797	AAG	221;224;223	A;A;G	221;224;223	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2676	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1858	178.3	1	SNP	p	D121N	0	.	.	361	363	GAC	798	800	GAC	221;223;221	G;A;C	221;223;221	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2676	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1858	178.3	1	SNP	p	A121D	1	.	.	361	363	GAC	798	800	GAC	221;223;221	G;A;C	221;223;221	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	8890	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	5385	206.0	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2264	2266	AAT	226;224;225	A;A;T,A	226;224;224,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1284	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1538	103.9	1	SNP	p	V57M	1	.	.	169	171	ATG	806	808	ATG	229;227;227	A;T;G,T	229;227;226,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
